CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-10 | Borthwick Kathleen SVP, INTERIM CFO | Option exercise · Restricted Stock Unit | −4,000 | 8,000 | ||
| 2024-02-10 | Forman Mark S CHIEF MEDICAL OFFICER | Option exercise | +5,000 | 50,269 | ||
| 2024-02-10 | Forman Mark S CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Unit | −5,000 | 10,000 | ||
| 2024-01-02 | Forman Mark S Chief Medical Officer | Sale | −15,813 | $0.91 | $14K | 45,269 |
| 2024-01-02 | Borthwick Kathleen SVP, Interim CFO | Sale | −10,672 | $0.91 | $10K | 25,936 |
| 2024-01-02 | Cale Edgar B. GC & Corporate Secretary | Sale | −15,813 | $0.91 | $14K | 45,995 |
| 2023-12-31 | Forman Mark S Chief Medical Officer | Option exercise | +50,000 | 61,082 | ||
| 2023-12-31 | Forman Mark S Chief Medical Officer | Option exercise · Restricted Stock Unit | −50,000 | 0 | ||
| 2023-12-31 | Borthwick Kathleen SVP, Interim CFO | Option exercise | +30,000 | 36,608 | ||
| 2023-12-31 | Borthwick Kathleen SVP, Interim CFO | Option exercise · Restricted Stock Unit | −30,000 | 0 | ||
| 2023-12-31 | Cale Edgar B. GC & Corporate Secretary | Option exercise | +50,000 | 61,808 | ||
| 2023-12-31 | Cale Edgar B. GC & Corporate Secretary | Option exercise · Restricted Stock Unit | −50,000 | 0 | ||
| 2023-07-28 | King Simona Chief Financial Officer | Option exercise | +31,250 | 35,447 | ||
| 2023-07-28 | King Simona Chief Financial Officer | Sale | −11,453 | $0.88 | $10K | 23,994 |
| 2023-07-28 | King Simona Chief Financial Officer | Option exercise · Restricted Stock Units | −31,250 | 0 | ||
| 2023-07-28 | Borthwick Kathleen SVP, Interim CFO | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-27 | Sondhi Dolan Director | Grant or award · Director Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2023-06-28 | ORBIMED ADVISORS LLC 10% owner | Purchase | +575,195 | $0.84 | $483K | 8,034,000 |
| 2023-06-27 | ORBIMED ADVISORS LLC 10% owner | Purchase | +617,382 | $0.84 | $519K | 7,458,805 |
| 2023-06-16 | Fotopoulos Alexandros Chief Technical Officer | Sale | −4,052 | $0.93 | $4K | 28,693 |
Page 5 of 8 · 152 trades